NCT07300241
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07300241
Title Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Neomorph, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
NEO-811 Grand Rapids Site RECRUITING Grand Rapids Michigan 49503 United States Details
NEO-811 Long Island Site RECRUITING Lake Success New York 11042 United States Details
NEO-811 South Carolina Site RECRUITING Myrtle Beach South Carolina 29572 United States Details
NEO-811 Dallas Site RECRUITING Dallas Texas 75039 United States Details
NEO-811 Houston Site RECRUITING Houston Texas 77054 United States Details
NEO-811 Virginia Site RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field